EPAS1 and breast cancer: SIPA1 knockdown as well as LDH inhibitor oxamate administration markedly inhibited breast cancer cell metastasis from primary xenografted sites to the lungs, suggesting that the blockade of glycolysis mediated by SIPA1/HIF-2α axis is an efficacious strategy for the treatment of aggressive breast cancer that expresses SIPA1.